SPAG8 inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of SPAG8, a protein known as Sperm Associated Antigen 8. SPAG8 is primarily expressed in the testis and is associated with sperm development and function. It is believed to play a critical role in the structural organization and motility of sperm, particularly during the process of spermatogenesis, where germ cells undergo a series of transformations to become mature, motile spermatozoa. SPAG8 is thought to interact with various components of the sperm cytoskeleton and axoneme, the core structure of the sperm tail, which is essential for the proper movement and propulsion of sperm cells. By inhibiting SPAG8, researchers can disrupt these key processes, providing a tool to study the specific contributions of SPAG8 to sperm structure, function, and overall fertility.
In research settings, SPAG8 inhibitors are valuable for exploring the molecular mechanisms by which SPAG8 contributes to sperm motility and the broader implications of its activity on male reproductive function. By blocking SPAG8 activity, scientists can investigate how the inhibition affects the formation and function of the sperm tail, particularly focusing on the impact on axonemal integrity and the ability of sperm to swim effectively. This inhibition allows researchers to study the downstream effects on sperm motility, fertility potential, and the overall process of spermatogenesis. Additionally, SPAG8 inhibitors provide insights into the interactions between SPAG8 and other proteins involved in sperm structure and motility, shedding light on the complex regulatory networks that ensure the proper development of functional sperm. Through these studies, the use of SPAG8 inhibitors enhances our understanding of the molecular underpinnings of sperm biology, the regulation of male fertility, and the broader implications of these processes for reproductive health.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Inhibits tyrosine kinases which can regulate signaling pathways that SPAG8 is involved in. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibitor of PI3K that can alter downstream signaling affecting SPAG8's activity or expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK which may be part of the MAPK/ERK pathway that SPAG8 is a component of. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAP kinase potentially influencing SPAG8 activity if it is involved in stress response pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Inhibits MEK1/2 in the MAPK/ERK pathway which could affect SPAG8 if it is linked to this pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K and can disrupt signaling pathways that may regulate SPAG8. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR which may affect SPAG8 if it is involved in cell growth or autophagy-related pathways. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
Src family kinase inhibitor that can affect signaling pathways regulating SPAG8. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, potentially affecting SPAG8 if it interacts with the JNK signaling pathway. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $150.00 $349.00 | 15 | |
Aurora kinase inhibitor that may alter cell cycle processes involving SPAG8. | ||||||